Lawrence Watkins Greer
Direktor/Vorstandsmitglied bei DiscoveryBioMed, Inc.
Ursprung des Netzwerks ersten Grades von Lawrence Watkins Greer
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
DiscoveryBioMed, Inc.
 DiscoveryBioMed, Inc. BiotechnologyHealth Technology DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.
5
| Subsidiary | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lawrence Watkins Greer
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The University of Alabama | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Amytrx Therapeutics, Inc.
 Amytrx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amytrx Therapeutics, Inc. developed biological medicines. The company was headquartered in Nashville, TN. | Pharmaceuticals: Major | Director/Board Member Founder | |
Greer Capital Advisors LLC
 Greer Capital Advisors LLC Investment ManagersFinance Greer Capital Advisors LLC (GCA) is a private equity/venture capital firm founded in 2002 by Lawrence W. Greer. The firm is headquartered in Mountain Brook, Alabama. | Investment Managers | Founder | |
| The University of Alabama at Birmingham | College/University | Doctorate Degree | |
| University of Idaho | College/University | Doctorate Degree | |
| University of Northern Iowa | College/University | Undergraduate Degree | |
| Grinnell College | College/University | Undergraduate Degree | |
| Dartmouth College | College/University | Doctorate Degree | |
| PREMD INC. | Medical Specialties | Chief Executive Officer | |
| OMNIMMUNE HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Genovo, Inc.
 Genovo, Inc. Medical SpecialtiesHealth Technology Part of Innoviva, Inc., Genovo, Inc. is a maker of gene and cell therapy products. The company is based in Sharon Hill, PA. Genovo was acquired by AmpliPhi Biosciences Corp. on September 20, 2000 for $84.53 million. | Medical Specialties | Chief Executive Officer | |
| George Mason University | College/University | Graduate Degree | |
| University of Virginia | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
CytoViva, Inc.
 CytoViva, Inc. Medical SpecialtiesHealth Technology CytoViva, Inc. provides optical microscopy-imaging systems. Its products include hyperspectral micropscopy, enhanced darkfield micropscopy and three dimensional enhanced darkfield microscopy. The company was founded by Samuel M. Lawrence and John O. Lawrence in 2005 and is headquartered in Auburn, AL. | Medical Specialties | Director/Board Member | |
PNP Therapeutics, Inc.
 PNP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PNP Therapeutics, Inc. operates as a biopharmaceutical company which develops a platform technology and proprietary products for the treatment of cancer. It offers E. coli purine nucleoside phosphorylase that work with nucleoside prodrugs generating active metabolites with anti-tumor activity. The company was founded by William B. Parker and Eric J. Sorscher and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Director/Board Member | |
Dunn Investment Co., Inc.
 Dunn Investment Co., Inc. Financial ConglomeratesFinance Dunn Investment Co., Inc. is a private company that specializes in asphalt and aggregates. Dunn Construction has five plants located in the greater Birmingham and surrounding areas, offering a wide variety of asphalt products suited for any need or application. The company is based in Birmingham, AL and has subsidiaries in the United States. The company has a vertically integrated approach to asphalt production and paving, as well as their own aggregate operation. The company has five paving crews, one milling crew, and three base crews, which allows them to carry out jobs of any size. The company also prioritizes community service and giving back to their community. | Financial Conglomerates | Chief Investment Officer | |
Southern BioSystems, Inc.
 Southern BioSystems, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., Southern BioSystems, Inc. is a company that manufactures and develops biodegradable polymer and non-polymer drug delivery systems. The company is based in Birmingham, AL. The company was founded by Alan H. Dean. Southern BioSystems was acquired by DURECT Corp. on April 30, 2001 for $13.64 million. | Medical Specialties | Chairman | |
Vivo Biosciences, Inc.
 Vivo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Vivo Biosciences, Inc. develops platform for preclinical research, drug discovery and therapeutics. Its products include ready to use HuBiogel, angio-start assay kit, custom products, and mini-tumor assay plates. It also offers pre-clinical drug testing services, efficient 3D bioassay platform, and other HuBiogel applications. The company was founded by Lawrence J. DeLucas and Raj K. Singh in 2004 and is headquartered in Birmingham, AL. | Pharmaceuticals: Major | Director/Board Member | |
Aetos Technologies, Inc.
 Aetos Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Aetos Technologies, Inc. is a technology development company. The firm offers funding and management services to commercialize and market technologies developed at research institutions. The company services include evaluation, product, process development, business management, and financing. Aetos Technologies was founded in 2003 and is headquartered in Auburn, AL. | Miscellaneous Commercial Services | Director/Board Member | |
| Emory University | College/University | Doctorate Degree | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
| CUMBERLAND PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Auburn University | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 27 |
| Kanada | 2 |
| Italien | 2 |
Sektoral
| Consumer Services | 13 |
| Health Technology | 11 |
| Finance | 4 |
| Health Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 13 |
| Undergraduate Degree | 5 |
| Doctorate Degree | 5 |
| Chief Executive Officer | 5 |
| Corporate Officer/Principal | 5 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Larry W. Greer | 13 |
| Matthew A. Gonda | 10 |
| John H. Streiff | 5 |
| Erik M. Schwiebert | 4 |
| Deborah Mai | 3 |
- Börse
- Insiders
- Lawrence Watkins Greer
- Unternehmensverbindungen
